Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant hypocalcemia in which the cause of the disease is a mutation in the CASR gene.
Features include always present findings: Muscle spasm and Hypocalcemia; and very common findings: Hypomagnesemia. 17 total HPO annotations.
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 6:03 PM UTC
Online Mendelian Inheritance in Man
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 3 | Nephrocalcinosis, Decreased glomerular filtration rate, Nephrolithiasis |
Brain and nerves | 2 | Paresthesia, Seizure |
Lab test results | 2 | Decreased circulating parathyroid hormone level, Increased circulating renin concentration |
Growth and development | 1 | Short stature |
Muscles | 1 | Muscle spasm |
CASR encodes calcium sensing receptor (1,078 aa). G-protein-coupled receptor that senses changes in the extracellular concentration of calcium ions and plays a key role in maintaining calcium homeostasis. Highest expression in Kidney Medulla (18.1 TPM) and Pancreas (3.5 TPM).
Autosomal dominant hypocalcemia 1 is caused by mutations in the CASR gene on chromosome 3.
The CASR protein participates in CASR:CASR agonists pathway.
CASR is classified as a druggable target (Cell Surface, Clinically Actionable, Druggable Genome, and G Protein Coupled Receptor categories) with score 6.1.
Genetic testing for CASR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal dominant hypocalcemia 1 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 1 very common feature, 5 common features.
No clinical trials have been registered for autosomal dominant hypocalcemia 1.
23 publications have been identified in PubMed for autosomal dominant hypocalcemia 1. Research spans Review / Meta-Analysis (35%), Case Report / Case Series (30%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 35% |
Patient case studies | 7 | 30% |
Disease patterns and progression | 3 | 13% |
Laboratory research | 2 | 9% |
New treatment approaches | 2 | 9% |
Testing and diagnosis research | 1 | 4% |
Chondrogianni ME (2026). [PMID: 40760326](https://pubmed.ncbi.nlm.nih.gov/40760326/). *Hormones (Athens)*. [Review / Meta-Analysis]
Bibik E (2026). [PMID: 41952051](https://pubmed.ncbi.nlm.nih.gov/41952051/). *Clin Endocrinol (Oxf)*. [Case Report / Case Series]
Harada D (2026). [PMID: 41732805](https://pubmed.ncbi.nlm.nih.gov/41732805/). *J Bone Miner Res*. [Review / Meta-Analysis]
Gao Y (2026). [PMID: 41801666](https://pubmed.ncbi.nlm.nih.gov/41801666/). *J Endocrinol Invest*. [Case Report / Case Series]
Fu M (2026). [PMID: 42181181](https://pubmed.ncbi.nlm.nih.gov/42181181/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Vincent A (2026). [PMID: 42161334](https://pubmed.ncbi.nlm.nih.gov/42161334/). *Eur J Endocrinol*. [Epidemiology / Natural History]
Mouandilmadji DM (2026). [PMID: 42153160](https://pubmed.ncbi.nlm.nih.gov/42153160/). *Pan Afr Med J*. [Case Report / Case Series]
Della Valentina S (2026). [PMID: 42223909](https://pubmed.ncbi.nlm.nih.gov/42223909/). *J Endocrinol Invest*. [Case Report / Case Series]
Charoenngam N (2025). [PMID: 39484850](https://pubmed.ncbi.nlm.nih.gov/39484850/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Du W (2025). [PMID: 39413244](https://pubmed.ncbi.nlm.nih.gov/39413244/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
AI-curated news mentioning autosomal dominant hypocalcemia 1
Updated Mar 30, 2026
A case report highlights a giant parathyroid adenoma that was initially obscured by severe vitamin D deficiency, presenting with hypocalcemia. This finding underscores the importance of considering parathyroid disorders in patients with vitamin D deficiency.
A new study discusses peri-kidney transplant management strategies for patients with autosomal dominant hypocalcaemia type 1. This research highlights the unique challenges faced during transplantation in this rare condition.